Filing Details
- Accession Number:
- 0000950142-15-002487
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-24 16:20:45
- Reporting Period:
- 2015-11-20
- Filing Date:
- 2015-11-24
- Accepted Time:
- 2015-11-24 16:20:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 270119051 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1172252 | N Andrew Schiff | 888 Seventh Avenue 12Th Floor New York NY 10106 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-11-20 | 155,992 | $30.27 | 2,197,742 | No | 4 | S | Indirect | By Aisling Capital III, LP |
Common Stock | Disposition | 2015-11-23 | 100,000 | $31.46 | 2,097,742 | No | 5 | S | Indirect | By Aisling Capital III, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Aisling Capital III, LP |
No | 5 | S | Indirect | By Aisling Capital III, LP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,938 | Direct |
Footnotes
- Consists of 3,495 shares of common stock, par value $0.001 per share ("Common Stock") and 3,443 restricted stock units, issued pursuant to the 2011 Equity Incentive Plan of the Issuer. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units vest in 12 ratable monthly installments from the date of grant, subject to Mr. Schiff's continued service with the Issuer. As previously reported, on June 17, 2015, Mr. Schiff was granted 4,996 such restricted stock units, of which 2,081 have vested to date. Also as previously reported, on July 22, 2015, Mr. Schiff was granted an additional 790 such restricted stock units, of which 262 have vested to date.
- Includes 87 shares of Common Stock held by a trust for the benefit of Mr. Schiff's children.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.82, inclusive.
- The Price reported in Column 4 is a weighted average price. Those shares were sold in multiple transactions at prices ranging from $31.06 to $31.93, inclusive.
- The shares are directly held by Aisling Capital III, LP ("Aisling") and are indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III, LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling. Dr. Andrew Schiff is a member of the Board of Directors of Zeltiq Aesthetics, Inc.
- The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) and (4) to this Form 4.